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Neonatal hyperbilirubinemia is a matter of concern for pediatricians worldwide. There is an unusual delay in the baby’s discharge with extra blood sampling to check 
the bilirubin levels at frequent time intervals. This adds to the 
concern and worry of the parents too [1]. Although transcutaneous 
bilirubinometer (TcB) measures the bilirubin levels in a safe, cost 
effective, and less invasive manner, there is uncertainty about 
replacing TcB with total serum bilirubin (TSB) [2,3].
Phototherapy (PT) has been widely used in pathological 
jaundice to reduce the bilirubin levels. Due to this, frequent blood 
sampling is carried out to check for reduction in bilirubin values. 
Once PT is stopped, sampling of rebound bilirubin is required. 
Most of the times, the parents are reluctant for further sampling, 
and hence, the baby’s condition or severity of jaundice cannot be 
reassessed, thus worsening the scenario.
The correlations between TcB and TSB have been researched 
and studied extensively. Studies have shown poor correlation 
during PT, but there are few studies that show the correlation 
before and after PT. The objective of the study is to find the 
correlation between TcB values with TSB in infants before PT 
and during rebound bilirubin assessment in term and late preterm 
babies.
MATERIALS AND METHODS
This was a prospective observational study from November 2014 
to June 2016 in a neonatal unit of a medical college hospital in 
South India. Inborn babies more than 34 weeks gestational age and 
having neonatal hyperbilirubinemia (NNH) were included in the 
study. Babies with established direct hyperbilirubinemia, neonatal 
septicemia, major congenital/gastrointestinal malformations, 
and those who were already on PT were excluded from the 
study. Based on a study conducted by Chakrabarti, correlation 
between transcultanoeus bilirubinometry and TSB after PT was 
r=0.3959 [4].
Sample size was calculated using the formula:
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Minimum sample size needed, n=48.
In the present study, 54 samples were collected. The study 
protocol was approved by the institutional review board and 
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ethics committee. Written informed consent was obtained from 
the parents. The clinical and dimorphic profile of the mother and 
the baby was collected using a pro forma.
TcB was estimated with Drager Jaundice Meter JM-105 by 
placing the instrument on the baby’s sternum. Sternum was taken 
as the principal site of measurement as several studies have shown 
excellent correlation with TcB compared to the other sites [5,6]. 
An average of three readings was taken as the TcB value. After 
each baby, the probe was cleaned with a sterile gauze before using 
for the next baby.
After the mother was explained about the procedure, 1 ml of 
venous blood was collected in a Microtainer clot activator tube 
for assessing TSB level under strict aseptic precautions after the 
mother was explained about the procedure. The blood samples 
were taken to the hospital laboratory within an hour to prevent 
degradation and processed. Serum bilirubin measurements 
were done using the diazo method (modified Jendrassik-Grof 
method) in the automated analyzer Cobas Integra 400 plus from 
Roche Diagnostics. The maximum interval of time between the 
transcutaneous measurement and the collection of blood for TSB 
was 30 min.
All babies were visually examined every 6 hours on the 1st day 
of life by a trained physician and twice a day thereafter. At 24 h, 
TSB and TcB were done for all babies. If PT was required, it was 
started according to the AAP guidelines [7]. PT lights used were 
the standard CFL 101 model (Phoenix Ltd) consisting of six CFL 
lights providing blue light at −30 µW/cm2/nm with an intensity of 
up to 40 µW. A pre-set height of 45 cm from the bed was made for 
the PT lights. The eyes and genitalia of the babies were covered 
before starting the procedure. PT units were maintained and used 
according to the manufacturer’s guidelines. Rebound TcB and 
TSB were taken for all babies, 12 h after stopping PT.
Data were entered into Microsoft Excel and analyzed using the 
SPSS version 20.0 for Windows software. Spearman’s correlation 
and Bland–Altman analysis were used for studying the data.
RESULTS
Of 1950 babies delivered in our hospital during the study period, 
396 babies had non-significant hyperbilirubinemia and 54 babies 
had significant hyperbilirubinemia and these were recruited in the 
study after considering the inclusion and exclusion criteria. Out of 
these, 23 (42.6%) were male and 31 (57.4%) were female. A total 
of 10 babies (18.5%) were late preterm and 42 (77.8%) were from 
37 to 39 weeks of gestation. Only 2 (3.7%) post-dated babies 
developed significant hyperbilirubinemia. Before starting PT, the 
mean TSB was 8.41±1.23 mg/dl and mean TcB was 9.93±1.43 mg/
dl. After PT, the mean TSB was 14.95±3.48 mg/dl and mean TcB 
was 15.58±3.57 mg/dl. The duration of phototherapy for all cases 
are shown in Figure 1, 52 babies received more than 24 h of 
phototherapy.
Rebound bilirubin was done in all infants receiving PT 8–12 h 
after discontinuation. The agreement between TcB and TSB was 
done using Bland–Altman plots. It showed excellent agreement 
for after phototherapy values (Rebound) with TcBI overestimates Figure 1: Distribution of cases as per the duration of phototherapy
Figure 2: Bland–Altman plot showing agreement between total serum bilirubin and transcutaneous bilirubinometer before and after 
phototherapy in the study population
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only 0.6mg/dl above the mean, when compared to before 
phototherapy with 1.5mg/dl, as shown in Figure 2. This means 
that the rebound TcB can be used instead of TSB. This not only 
reduces the hospital stay but also unnecessary blood sampling in 
these babies for rebound values.
In term and preterm babies, there was over estimation by 
1.5mg/dl before phototherapy and just 0.6mg/dl after stopping 
phototherapy as shown in Figures 3 and 4.
As shown in Figure 5, before phototherapy, the spearman 
correlation coefficients for the entire cohort, term and preterm 
babies were R= 0.917, 0.891 and 0.876. Once phototherapy was 
stopped, the correlation coefficients improved to R= 0.994, 0.994 
and 1.0 respectively.
Table 1 shows that after PT, the difference between TSB and 
TcB remained higher compared to before PT for all the babies, 
irrespective of gestational age.
DISCUSSION
Transcutaneous bilirubinometry has been extensively used as a 
substitute for serum bilirubin as it is reliable, safe, quick, and cost 
effective. However, when the babies are subjected to PT, TSB 
still continues to be the ideal choice of many pediatricians for 
assessing the progression of jaundice. There have been conflicting 
ideas when their correlation is discussed with differing basic 
characteristics such as site of assessment, covered and exposed 
regions, type of lights, and type (continuous or intermittent) of 
PT. With the initiation of PT, a rapid decrement in dermal bilirubin 
is caused by photoisomerization of albumin-bound bilirubin in 
interstitial places and subcutaneous capillaries into lumirubin 
and other photoisomers [8]. Studies have shown that the rate of 
decrease of dermal bilirubin as measured by TcB is non-linear 
with respect to the duration of PT. TSB shows an exponential 
decline that is independent of the logarithm of light dose. Skin 
bilirubin decreases more than the plasma bilirubin causing the 
bilirubin gradient between the two.
There have been studies showing the poor correlation between 
the two during the PT. However, once it is stopped, the correlation 
seems to improve as the bleaching effect is also reduced and 
hence overtime, the skin color returns to normal. There have been 
very few studies proving that post-PT, the correlation improves. 
In a meta-analysis, the correlation between TcB and TSB readings 
improved marginally following discontinuation of PT (r = 0.72, 
95% CI 0.64–0.78) [9]. Tan and Dong noted further improvement 
in the correlation coefficients on the 2nd day after PT as compared 
to the first reading taken 18–24 h after discontinuation of PT [10].
In another study, though TcB underestimated TSB within the 
first 8 h after cessation of PT, thereafter, the difference returned 
Figure 3: Bland–Altman plot showing agreement, in term babies, between total serum bilirubin and transcutaneous bilirubinometer before 
and after phototherapy
Table 1: TSB and TCB levels before and after PT
Study population Time Bilirubin levels (mg/dl) Mean+SD p‑value
TcB TSB TcB‑TSB
Entire Cohort (n=54) Before PT 9.9 (±1.4) 8.4 (±1.2) 1.5 (±0.5) <0.001
After PT 15.6 (±3.6) 14.9 (±3.5) 0.6 (±0.4) <0.001
Term babies (n=43) Before PT 10.2 (±1.3) 8.7 (±1.1) 1.6 (±0.5) <0.001
After PT 15.7 (±3.6) 15.1 (±3.5) 0.6 (±0.3) <0.001
Preterm babies (n=11) Before PT 8.7 (±1.3) 7.3 (±1.1) 1.4 (±0.5) <0.001
After PT 15.1 (±3.6) 14.5 (±3.7) 0.6 (±0.6) 0.005
TSB: Total serum bilirubin, TcB: Transcutaneous bilirubinometer
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to pre-treatment levels and thus 43% of post-PT punctures could 
have been avoided [11]. Juster-Reicher et al. showed that the 
correlation was low during the first 8h after PT (r=0.56), but 
thereafter the correlation returned to the range of 0.65–0.8 [12]. 
A study in preterm babies of 30–34 weeks gestation also showed 
a strong correlation between TcB and TSB measurements post-
therapy (r=0.869, p<0.001) [13]. Nagar and Kumar showed that 
in post-PT phase, correlation coefficients improved significantly 
and were equivalent to the estimates before starting PT (r=0.88 at 
forehead and 0.87 at sternum) [14]. This study showed that once 
Figure 4: Bland–Altman plot showing agreement, in preterm babies, between total serum bilirubin and transcutaneous bilirubinometer before 
and after phototherapy
R = 0.917
P<0.001
R =0.891
P<0.001
R=0.876
P<0.001
Before phototherapy
a b c
Figure 5: Graphs showing the Spearman correlation for the entire study population, term and preterm babies after phototherapy. (a) Entire 
cohort, (b) term babies, (c) preterm babies
R = 0.994
P<0.001
R = 0.994
P<0.001
R = 1.0
P<0.001
a b c
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PT was stopped, the correlation between TSB and TcB remained 
significant (r=0.990). All the rebound bilirubin values were taken 
at the end of 12 h of stopping PT. Thus, the blood samples post-PT 
could be reduced and even the duration of hospital stay.
The time duration at which correlation was higher between 
TcB and TSB, has always been a challenging conflict between 
many pediatricians. There was one prospective study by Casnocha 
Lucanova et al. that proved that 2 h post-PT, the correlation 
between TSB and TcB was poor. They attributed the reason for 
this early sampling due to early discharge of the babies [15]. On 
the other hand, Hulzebos et al. proved that the length of time 
after stopping PT did not appear to have a statistically significant 
effect on the mean differences between TSB and TcB [16]. Most 
of the above studies that prove correlation showed excellent 
correlation after 8 h of cessation of PT [10-12]. Our study showed 
a correlation at 12 h after PT was stopped.
This study was the first of its kind to be done in the South 
Indian population. However, it has some limitations too. First, it is 
not a population-based study and it represents the data of a single 
tertiary care hospital in South India. Small number of preterms in 
our study precludes any meaningful assessment in this subgroup, 
and larger studies in preterms of various maturity and nutritional 
states are, therefore, needed. We also studied only the correlation 
after 12 h of PT, but we did not follow these patients after 12 h 
post-PT to further study the correlation.
CONCLUSION
This study proves that post-PT, the correlation between TSB and 
TcB is excellent in both term and preterm babies, making TcB a 
much ideal choice for pediatricians all over the world. This not 
only reduces the duration and cost of stay of hospitalization of 
babies but also excess blood sampling post-PT. More studies with 
a bigger sample size are required.
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